FSTL3 and cardiac hypertrophy: FSTL3 has also been characterized as a stress-induced regulator of cardiac hypertrophy through Smad signalling pathway modulation in a mouse model (35), opening an opportunity for investigation of the follistatin family of proteins as a therapeutic target for the protection against HF.